vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and FTAI Infrastructure Inc. (FIP). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $143.5M, roughly 1.3× FTAI Infrastructure Inc.). AVANOS MEDICAL, INC. runs the higher net margin — -0.7% vs -68.1%, a 67.4% gap on every dollar of revenue. On growth, FTAI Infrastructure Inc. posted the faster year-over-year revenue change (77.7% vs 0.7%). AVANOS MEDICAL, INC. produced more free cash flow last quarter ($21.3M vs $-68.6M). Over the past eight quarters, FTAI Infrastructure Inc.'s revenue compounded faster (31.9% CAGR vs 4.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
FTAI Infrastructure Inc. owns, operates and invests in high-quality critical infrastructure assets across core sectors including transportation logistics, midstream energy, and power generation. It primarily serves North American markets, focusing on assets with stable long-term cash flows, contracted revenue streams, and strong market positions to deliver sustainable returns for stakeholders.
AVNS vs FIP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $143.5M |
| Net Profit | $-1.3M | $-97.7M |
| Gross Margin | 47.5% | — |
| Operating Margin | 1.4% | -45.7% |
| Net Margin | -0.7% | -68.1% |
| Revenue YoY | 0.7% | 77.7% |
| Net Profit YoY | 99.7% | 21.6% |
| EPS (diluted) | $-0.02 | $-1.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $143.5M | ||
| Q3 25 | $177.8M | $140.6M | ||
| Q2 25 | $175.0M | $122.3M | ||
| Q1 25 | $167.5M | $96.2M | ||
| Q4 24 | $179.6M | $80.8M | ||
| Q3 24 | $170.4M | $83.3M | ||
| Q2 24 | $171.7M | $84.9M | ||
| Q1 24 | $166.1M | $82.5M |
| Q4 25 | $-1.3M | $-97.7M | ||
| Q3 25 | $-1.4M | $-104.5M | ||
| Q2 25 | $-76.8M | $-70.0M | ||
| Q1 25 | $6.6M | $120.2M | ||
| Q4 24 | $-397.3M | $-124.7M | ||
| Q3 24 | $4.3M | $-43.0M | ||
| Q2 24 | $1.8M | $-48.1M | ||
| Q1 24 | $-900.0K | $-50.3M |
| Q4 25 | 47.5% | — | ||
| Q3 25 | 48.4% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.6% | — | ||
| Q4 24 | 54.6% | — | ||
| Q3 24 | 54.5% | — | ||
| Q2 24 | 55.7% | — | ||
| Q1 24 | 57.1% | — |
| Q4 25 | 1.4% | -45.7% | ||
| Q3 25 | 0.1% | -70.8% | ||
| Q2 25 | -42.6% | -56.4% | ||
| Q1 25 | 6.1% | 81.8% | ||
| Q4 24 | -233.0% | -152.7% | ||
| Q3 24 | 7.0% | -51.7% | ||
| Q2 24 | 3.7% | -56.4% | ||
| Q1 24 | 2.4% | -58.8% |
| Q4 25 | -0.7% | -68.1% | ||
| Q3 25 | -0.8% | -74.4% | ||
| Q2 25 | -43.9% | -57.2% | ||
| Q1 25 | 3.9% | 125.0% | ||
| Q4 24 | -221.2% | -154.4% | ||
| Q3 24 | 2.5% | -51.6% | ||
| Q2 24 | 1.0% | -56.7% | ||
| Q1 24 | -0.5% | -60.9% |
| Q4 25 | $-0.02 | $-1.04 | ||
| Q3 25 | $-0.03 | $-1.38 | ||
| Q2 25 | $-1.66 | $-0.73 | ||
| Q1 25 | $0.14 | $0.89 | ||
| Q4 24 | $-8.64 | $-1.21 | ||
| Q3 24 | $0.09 | $-0.45 | ||
| Q2 24 | $0.04 | $-0.52 | ||
| Q1 24 | $-0.02 | $-0.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $57.4M |
| Total DebtLower is stronger | $90.3M | $3.8B |
| Stockholders' EquityBook value | $778.2M | $21.3M |
| Total Assets | $1.1B | $5.7B |
| Debt / EquityLower = less leverage | 0.12× | 176.99× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $57.4M | ||
| Q3 25 | $70.5M | $34.7M | ||
| Q2 25 | $90.3M | $33.6M | ||
| Q1 25 | $97.0M | $26.3M | ||
| Q4 24 | $107.7M | $27.8M | ||
| Q3 24 | $89.0M | $20.3M | ||
| Q2 24 | $92.2M | $33.1M | ||
| Q1 24 | $75.8M | $23.0M |
| Q4 25 | $90.3M | $3.8B | ||
| Q3 25 | $93.4M | $3.7B | ||
| Q2 25 | $95.7M | $3.1B | ||
| Q1 25 | $98.0M | $2.8B | ||
| Q4 24 | $125.3M | $1.6B | ||
| Q3 24 | $152.6M | $1.5B | ||
| Q2 24 | $164.9M | $1.6B | ||
| Q1 24 | $167.2M | $1.3B |
| Q4 25 | $778.2M | $21.3M | ||
| Q3 25 | $778.0M | $181.1M | ||
| Q2 25 | $776.3M | $375.5M | ||
| Q1 25 | $839.4M | $476.2M | ||
| Q4 24 | $828.5M | $202.7M | ||
| Q3 24 | $1.2B | $370.8M | ||
| Q2 24 | $1.2B | $394.8M | ||
| Q1 24 | $1.2B | $402.5M |
| Q4 25 | $1.1B | $5.7B | ||
| Q3 25 | $1.1B | $5.5B | ||
| Q2 25 | $1.0B | $4.4B | ||
| Q1 25 | $1.1B | $4.1B | ||
| Q4 24 | $1.2B | $2.4B | ||
| Q3 24 | $1.7B | $2.4B | ||
| Q2 24 | $1.7B | $2.5B | ||
| Q1 24 | $1.7B | $2.3B |
| Q4 25 | 0.12× | 176.99× | ||
| Q3 25 | 0.12× | 20.59× | ||
| Q2 25 | 0.12× | 8.21× | ||
| Q1 25 | 0.12× | 5.79× | ||
| Q4 24 | 0.15× | 7.84× | ||
| Q3 24 | 0.12× | 4.14× | ||
| Q2 24 | 0.13× | 3.94× | ||
| Q1 24 | 0.14× | 3.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $-2.8M |
| Free Cash FlowOCF − Capex | $21.3M | $-68.6M |
| FCF MarginFCF / Revenue | 11.8% | -47.8% |
| Capex IntensityCapex / Revenue | 3.8% | 45.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $-398.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $-2.8M | ||
| Q3 25 | $14.0M | $-24.4M | ||
| Q2 25 | $6.8M | $-5.2M | ||
| Q1 25 | $25.7M | $-85.7M | ||
| Q4 24 | $57.9M | $-8.1M | ||
| Q3 24 | $23.0M | $14.2M | ||
| Q2 24 | $27.8M | $-17.6M | ||
| Q1 24 | $-8.0M | $-3.9M |
| Q4 25 | $21.3M | $-68.6M | ||
| Q3 25 | $7.0M | $-90.7M | ||
| Q2 25 | $-4.2M | $-87.5M | ||
| Q1 25 | $19.0M | $-151.7M | ||
| Q4 24 | $53.1M | $-34.3M | ||
| Q3 24 | $20.0M | $-11.7M | ||
| Q2 24 | $21.9M | $-32.1M | ||
| Q1 24 | $-12.1M | $-16.7M |
| Q4 25 | 11.8% | -47.8% | ||
| Q3 25 | 3.9% | -64.5% | ||
| Q2 25 | -2.4% | -71.6% | ||
| Q1 25 | 11.3% | -157.7% | ||
| Q4 24 | 29.6% | -42.4% | ||
| Q3 24 | 11.7% | -14.0% | ||
| Q2 24 | 12.8% | -37.9% | ||
| Q1 24 | -7.3% | -20.3% |
| Q4 25 | 3.8% | 45.9% | ||
| Q3 25 | 3.9% | 47.2% | ||
| Q2 25 | 6.3% | 67.3% | ||
| Q1 25 | 4.0% | 68.6% | ||
| Q4 24 | 2.7% | 32.5% | ||
| Q3 24 | 1.8% | 31.1% | ||
| Q2 24 | 3.4% | 17.2% | ||
| Q1 24 | 2.5% | 15.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.89× | -0.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.35× | — | ||
| Q2 24 | 15.44× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
FIP
| Power Revenues | $45.9M | 32% |
| Rail Revenue | $44.6M | 31% |
| Service Other | $22.8M | 16% |
| Gas Revenues | $15.3M | 11% |
| Roadside Services Revenues | $11.5M | 8% |
| Rapauno | $1.2M | 1% |
